Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Structural analysis of the Plasmodium V-ATPase bound to candidate antimalarial drugs
EF 2022-23
Résumé
Malaria, a disease caused by infection of red blood cells by single-celled Plasmodium parasites, imposes a significant health burden around the world. Over half the world’s population is exposed to malaria, causing 241 million cases and 627,000 deaths in 2020 alone. These malaria infections are increasingly drug resistant, so discovery of new malaria treatments is needed.
Plasmodium parasites possess an important molecule called the V-ATPase. The V-ATPase is responsible for controlling the acidity of different parts of the Plasmodium cell and helps the parasite acidify the red blood cell it infects. Recent experiments identified the Plasmodium V-ATPase as a target for antimalarial molecules because blocking the V-ATPase results in Plasmodium cell death.
We will determine the atomic structure of the Plasmodium V-ATPase bound to new antimalarial drugs. We will use an approach called electron cryomicroscopy to reveal the positions of all the atoms in the V-ATPase and the bound drug candidates. Determining the high-resolution structure of the Plasmodium V-ATPase bound to candidate antimalarial drugs will guide the iterative design and development of safer, more effective antimalarials, helping to reduce the global health burden of malaria.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
486287
Name
Karimi Ryan
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Structural analysis of the Plasmodium V-ATPase bound to candidate antimalarial drugs
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Anti-Malarial Drugs; Bioid; Cryo-Em; Malaria; Plasmodium; Proximity Labeling; Structural Biology; Vacuolar-Type Atpase
Abstract
Malaria, a disease caused by infection of red blood cells by single-celled Plasmodium parasites, imposes a significant health burden around the world. Over half the world’s population is exposed to malaria, causing 241 million cases and 627,000 deaths in 2020 alone. These malaria infections are increasingly drug resistant, so discovery of new malaria treatments is needed.
Plasmodium parasites possess an important molecule called the V-ATPase. The V-ATPase is responsible for controlling the acidity of different parts of the Plasmodium cell and helps the parasite acidify the red blood cell it infects. Recent experiments identified the Plasmodium V-ATPase as a target for antimalarial molecules because blocking the V-ATPase results in Plasmodium cell death.
We will determine the atomic structure of the Plasmodium V-ATPase bound to new antimalarial drugs. We will use an approach called electron cryomicroscopy to reveal the positions of all the atoms in the V-ATPase and the bound drug candidates. Determining the high-resolution structure of the Plasmodium V-ATPase bound to candidate antimalarial drugs will guide the iterative design and development of safer, more effective antimalarials, helping to reduce the global health burden of malaria.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Karimi, Ryan
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~